Login to Your Account



Financings Roundup

Merrimack Pharmaceuticals' Series G Brings in $77M

By Catherine Shaffer


Monday, April 18, 2011
Merrimack Pharmaceuticals Inc. raised $77 million in a Series G to finance its full house of five clinical-stage cancer candidates, plus a trio of preclinical candidates and multiple research-stage programs.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription